Plans de santé de l'État : Questions médicales fréquentes
Nom anglais: State Health Plans
Descriptor UI:D013221
Tree Number:N03.349.650.480
Questions fréquentes et termes MeSH associés
Diagnostic
2
#1
Comment évaluer l'efficacité d'un plan de santé de l'État ?
L'efficacité se mesure par l'accès aux soins, la qualité des services et la satisfaction des usagers.
Évaluation des programmesAccès aux soins
#2
Quels indicateurs de santé sont utilisés dans ces plans ?
Les indicateurs incluent la mortalité, la morbidité, l'accès aux soins et la satisfaction des patients.
Indicateurs de santéMortalité
Symptômes
2
#1
Quels symptômes peuvent indiquer un besoin de plan de santé ?
Des symptômes tels que des douleurs chroniques ou des maladies non traitées peuvent signaler un besoin.
SymptômesMaladies chroniques
#2
Comment les symptômes affectent-ils l'accès aux soins ?
Des symptômes graves peuvent limiter l'accès aux soins en raison de coûts ou de disponibilité.
Accès aux soinsSymptômes
Prévention
2
#1
Quelles mesures préventives sont proposées ?
Les mesures incluent des vaccinations, des dépistages et des programmes de sensibilisation.
PréventionVaccination
#2
Comment évaluer l'impact des mesures préventives ?
L'impact est évalué par la réduction des maladies et l'amélioration des indicateurs de santé.
Évaluation des programmesImpact sur la santé
Traitements
2
#1
Quels traitements sont couverts par les plans de santé de l'État ?
Les traitements incluent les soins préventifs, les hospitalisations et les médicaments essentiels.
Traitements médicauxSoins préventifs
#2
Comment les traitements sont-ils choisis dans ces plans ?
Les traitements sont choisis en fonction de l'efficacité, des coûts et des besoins de la population.
Choix des traitementsEfficacité des soins
Complications
2
#1
Quelles complications peuvent survenir sans plan de santé ?
Sans plan, des complications comme des maladies avancées et des hospitalisations fréquentes peuvent survenir.
ComplicationsMaladies avancées
#2
Comment les complications sont-elles gérées dans ces plans ?
Les complications sont gérées par des soins appropriés, un suivi régulier et des traitements adaptés.
Gestion des complicationsSuivi médical
Facteurs de risque
2
#1
Quels facteurs de risque sont pris en compte ?
Les facteurs incluent l'âge, le statut socio-économique, et les antécédents médicaux.
Facteurs de risqueAntécédents médicaux
#2
Comment les facteurs de risque influencent-ils les plans de santé ?
Ils influencent la conception des programmes et les priorités de santé publique pour la population.
Santé publiqueConception des programmes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Plans de santé de l'État : Questions médicales les plus fréquentes",
"headline": "Plans de santé de l'État : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Plans de santé de l'État : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-10",
"dateModified": "2026-04-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Plans de santé de l'État"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Planification régionale de la santé",
"url": "https://questionsmedicales.fr/mesh/D012040",
"about": {
"@type": "MedicalCondition",
"name": "Planification régionale de la santé",
"code": {
"@type": "MedicalCode",
"code": "D012040",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.349.650"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Children's health insurance program (USA)",
"alternateName": "Children's Health Insurance Program",
"url": "https://questionsmedicales.fr/mesh/D065326",
"about": {
"@type": "MedicalCondition",
"name": "Children's health insurance program (USA)",
"code": {
"@type": "MedicalCode",
"code": "D065326",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.349.650.480.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Plans de santé de l'État",
"alternateName": "State Health Plans",
"code": {
"@type": "MedicalCode",
"code": "D013221",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ligia Bahia",
"url": "https://questionsmedicales.fr/author/Ligia%20Bahia",
"affiliation": {
"@type": "Organization",
"name": "Instituto de Estudos em Saúde Coletiva, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Gail Tomblin Murphy",
"url": "https://questionsmedicales.fr/author/Gail%20Tomblin%20Murphy",
"affiliation": {
"@type": "Organization",
"name": "Nova Scotia Health Authority, Halifax, NS, Canada."
}
},
{
"@type": "Person",
"name": "Janet Rigby",
"url": "https://questionsmedicales.fr/author/Janet%20Rigby",
"affiliation": {
"@type": "Organization",
"name": "World Health Organization/Pan American Health Organization (WHO/PAHO) Collaborating Centre on Health Workforce Planning and Research, Dalhousie University, Halifax, NS, Canada."
}
},
{
"@type": "Person",
"name": "Doris Osei Afriyie",
"url": "https://questionsmedicales.fr/author/Doris%20Osei%20Afriyie",
"affiliation": {
"@type": "Organization",
"name": "Organisation mondiale de la Sante pour Afrique, Brazzaville, Congo."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The state of health information organizations and plans to participate in the federal exchange framework.",
"datePublished": "2024-08-21",
"url": "https://questionsmedicales.fr/article/39188926",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/haschl/qxae098"
}
},
{
"@type": "ScholarlyArticle",
"name": "[The contribution of health conferences and health regions to regional planning and management in health care: an overview at the federal states level].",
"datePublished": "2023-10-10",
"url": "https://questionsmedicales.fr/article/37816385",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2098-3496"
}
},
{
"@type": "ScholarlyArticle",
"name": "Correction to: The state of health information organizations and plans to participate in the federal exchange framework.",
"datePublished": "2024-10-15",
"url": "https://questionsmedicales.fr/article/39411455",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/haschl/qxae130"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Survey of State Correctional Health Care Providers on Advance Care Planning: Opportunity for Collaboration With Corrections.",
"datePublished": "2024-01-27",
"url": "https://questionsmedicales.fr/article/38279955",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10499091241226638"
}
},
{
"@type": "ScholarlyArticle",
"name": "Utilization of health-related data in the regional context for health service planning in the Federal State of Brandenburg, Germany-a qualitative study.",
"datePublished": "2024-09-25",
"url": "https://questionsmedicales.fr/article/39317799",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s43999-024-00050-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Planification régionale de la santé",
"item": "https://questionsmedicales.fr/mesh/D012040"
},
{
"@type": "ListItem",
"position": 4,
"name": "Plans de santé de l'État",
"item": "https://questionsmedicales.fr/mesh/D013221"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Plans de santé de l'État - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Plans de santé de l'État",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Plans de santé de l'État",
"description": "Comment évaluer l'efficacité d'un plan de santé de l'État ?\nQuels indicateurs de santé sont utilisés dans ces plans ?",
"url": "https://questionsmedicales.fr/mesh/D013221#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Plans de santé de l'État",
"description": "Quels symptômes peuvent indiquer un besoin de plan de santé ?\nComment les symptômes affectent-ils l'accès aux soins ?",
"url": "https://questionsmedicales.fr/mesh/D013221#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Plans de santé de l'État",
"description": "Quelles mesures préventives sont proposées ?\nComment évaluer l'impact des mesures préventives ?",
"url": "https://questionsmedicales.fr/mesh/D013221#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Plans de santé de l'État",
"description": "Quels traitements sont couverts par les plans de santé de l'État ?\nComment les traitements sont-ils choisis dans ces plans ?",
"url": "https://questionsmedicales.fr/mesh/D013221#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Plans de santé de l'État",
"description": "Quelles complications peuvent survenir sans plan de santé ?\nComment les complications sont-elles gérées dans ces plans ?",
"url": "https://questionsmedicales.fr/mesh/D013221#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Plans de santé de l'État",
"description": "Quels facteurs de risque sont pris en compte ?\nComment les facteurs de risque influencent-ils les plans de santé ?",
"url": "https://questionsmedicales.fr/mesh/D013221#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un plan de santé de l'État ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité se mesure par l'accès aux soins, la qualité des services et la satisfaction des usagers."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de santé sont utilisés dans ces plans ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les indicateurs incluent la mortalité, la morbidité, l'accès aux soins et la satisfaction des patients."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un besoin de plan de santé ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes tels que des douleurs chroniques ou des maladies non traitées peuvent signaler un besoin."
}
},
{
"@type": "Question",
"name": "Comment les symptômes affectent-ils l'accès aux soins ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves peuvent limiter l'accès aux soins en raison de coûts ou de disponibilité."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives sont proposées ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mesures incluent des vaccinations, des dépistages et des programmes de sensibilisation."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact des mesures préventives ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'impact est évalué par la réduction des maladies et l'amélioration des indicateurs de santé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont couverts par les plans de santé de l'État ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les soins préventifs, les hospitalisations et les médicaments essentiels."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils choisis dans ces plans ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements sont choisis en fonction de l'efficacité, des coûts et des besoins de la population."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans plan de santé ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans plan, des complications comme des maladies avancées et des hospitalisations fréquentes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées dans ces plans ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par des soins appropriés, un suivi régulier et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont pris en compte ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le statut socio-économique, et les antécédents médicaux."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque influencent-ils les plans de santé ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils influencent la conception des programmes et les priorités de santé publique pour la population."
}
}
]
}
]
}
Nova Scotia Health Authority, Halifax, NS, Canada.
World Health Organization/Pan American Health Organization (WHO/PAHO) Collaborating Centre on Health Workforce Planning and Research, Dalhousie University, Halifax, NS, Canada.
World Health Organization/Pan American Health Organization (WHO/PAHO) Collaborating Centre on Health Workforce Planning and Research, Dalhousie University, Halifax, NS, Canada.
In late 2023, the Office of the National Coordinator for Health Information Technology launched the Trusted Exchange Framework and Common Agreement (TEFCA) to enable nationwide health information exch...
Demands for increased health care coordination and cooperation have been raised for a long time in Germany. Over the past years, the public health services in the federal states have initiated network...
Prison populations are rapidly aging. Persons in prison age quicker and suffer more chronic illness and disability than their nonincarcerated peers, posing challenges to caring for prisoners who are c...
Utilizing regional health data goes hand in hand with challenges: can they be used for health planning, are they applicable to the relevant topics? The study explores current data utilization and need...
We conducted 16 semi-structured expert-interviews with stakeholders of regional health planning in Brandenburg, a federal state in the north-east of Germany, by telephone or online-meeting tools betwe...
Utilization of data sources depends on individual knowledge and personnel resources instead of being guided by standardized procedures. Interviewees primarily use internal data; some use many differen...
Actors in health planning primarily utilized their own data for planning; additional data sources are not available or the level of aggregation is too high, not known by them or are often not used due...
Expanding and managing current habitat and species protection measures is at the heart of the European biodiversity strategy. A structured approach is needed to gain insights into such issues is syste...
The objective of this review is to provide an update on planned oocyte cryopreservation. This fertility preservation method increases reproductive autonomy by allowing women to postpone childbearing w...
Etranacogene dezaparvovec is a recently approved gene therapy for people with hemophilia B (PwHB). Current standard of care is prophylaxis with factor IX (FIX) to prevent bleeding. Etranacogene dezapa...
To estimate the budgetary impact of etranacogene dezaparvovec adoption and utilization in a commercial health plan of the United States....
A budget impact model was developed to evaluate the introduction of etranacogene dezaparvovec to treat severe or moderately severe hemophilia B. The model considered a hypothetical 1-million-member pl...
In the 1-million-member health plan, an estimated 1.8 PwHB were eligible for treatment with etranacogene dezaparvovec. Gradual uptake of etranacogene dezaparvovec resulted in cumulative 5-year budget ...
Introducing etranacogene dezaparvovec as treatment for PwHB would have a modest budget increase within 5 years after treatment but may become cost saving if all eligible PwHB were treated in year 1. I...
Delay in surgical treatment for carpal tunnel syndrome (CTS) may result in long-term decreased functional outcomes. Few investigators have examined the relationship between type of health insurance pl...
This was a retrospective cohort study using the MarketScan Commercial Claims and Encounters Database 2011-2020. We used χ...
Overall, 28% of high-deductible health plan (HDHP) patients underwent carpal tunnel release, compared with 20% of traditional insurance patients (...
Patients with HDHPs who receive a diagnosis of CTS are more likely to undergo surgery, with a shorter time lag between diagnosis and surgery. The results from this study call attention to differences ...
Biosecurity practices aim to reduce the frequency of disease outbreaks in a farm, region, or country and play a pivotal role in fortifying the country's pork industry against emerging threats, particu...